Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mineral density and renal safety biomarkers at week 48. We report outcome...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The lancet HIV Ročník 8; číslo 7; s. e397
Hlavní autoři:	Ogbuagu, Onyema, Ruane, Peter J, Podzamczer, Daniel, Salazar, Laura C, Henry, Keith, Asmuth, David M, Wohl, David, Gilson, Richard, Shao, Yongwu, Ebrahimi, Ramin, Cox, Stephanie, Kintu, Alexander, Carter, Christoph, Das, Moupali, Baeten, Jared M, Brainard, Diana M, Whitlock, Gary, Brunetta, Jason M, Kronborg, Gitte, Spinner, Christoph D
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands 01.07.2021
Témata:	Adenine - adverse effects Adenine - analogs & derivatives Adenine - therapeutic use Adult Aged Alanine - adverse effects Alanine - therapeutic use Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Double-Blind Method Drug Therapy, Combination - adverse effects Emtricitabine - adverse effects Emtricitabine - therapeutic use Female Follow-Up Studies HIV Infections - prevention & control HIV Infections - virology HIV-1 - drug effects HIV-1 - physiology Humans Male Middle Aged Organophosphonates - adverse effects Organophosphonates - therapeutic use Pre-Exposure Prophylaxis Tenofovir - adverse effects Tenofovir - therapeutic use Treatment Outcome Young Adult
ISSN:	2352-3018, 2352-3018
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!